Lorcaserin Extended-Release Tablets and Rituximab and Hyaluronidase
Determining the interaction of Lorcaserin Extended-Release Tablets and Rituximab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Hyaluronidase and rituximab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Rituximab and hyaluronidase human, recombinant Subcutaneous
- Lorcaserin Extended-Release Tablets-Rituximab Intravenous
- Lorcaserin Extended-Release Tablets-Riva-Amoxicillin
- Lorcaserin Extended-Release Tablets-Rivaroxaban
- Lorcaserin Extended-Release Tablets-Rivastigmine
- Lorcaserin Extended-Release Tablets-Rivastigmine Capsules
- Rituximab and Hyaluronidase-Lorcaserin Hydrochloride
- Rituximab and Hyaluronidase-Lorcaserin Tablets
- Rituximab and Hyaluronidase-Lorcet
- Rituximab and Hyaluronidase-Lorcet Plus
- Rituximab and Hyaluronidase-Lorcet Tablets
- Rituximab and Hyaluronidase-Lorlatinib